These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 36441766)
21. A critical role for the regulation of Syk from agglutination to aggregation in human platelets. Shih CH; Chiang TB; Wang WJ Biochem Biophys Res Commun; 2014 Jan; 443(2):580-5. PubMed ID: 24326074 [TBL] [Abstract][Full Text] [Related]
22. Galectin-9 activates platelet ITAM receptors glycoprotein VI and C-type lectin-like receptor-2. Zhi Z; Jooss NJ; Sun Y; Colicchia M; Slater A; Moran LA; Cheung HYF; Di Y; Rayes J; Poulter NS; Watson SP; Iqbal AJ J Thromb Haemost; 2022 Apr; 20(4):936-950. PubMed ID: 34936188 [TBL] [Abstract][Full Text] [Related]
23. Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1. Tourdot BE; Brenner MK; Keough KC; Holyst T; Newman PJ; Newman DK Biochemistry; 2013 Apr; 52(15):2597-608. PubMed ID: 23418871 [TBL] [Abstract][Full Text] [Related]
24. Cyclic AMP-insensitive activation of c-Src and Syk protein-tyrosine kinases through platelet membrane glycoprotein VI. Ichinohe T; Takayama H; Ezumi Y; Yanagi S; Yamamura H; Okuma M J Biol Chem; 1995 Nov; 270(47):28029-36. PubMed ID: 7499287 [TBL] [Abstract][Full Text] [Related]
25. ITAM-derived phosphopeptide-containing dendrimers as multivalent ligands for Syk tandem SH2 domain. Kuil J; Branderhorst HM; Pieters RJ; de Mol NJ; Liskamp RM Org Biomol Chem; 2009 Oct; 7(19):4088-94. PubMed ID: 19763316 [TBL] [Abstract][Full Text] [Related]
26. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide. Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001 [TBL] [Abstract][Full Text] [Related]
27. RGD-ligand mimetic antagonists of integrin alphaIIbbeta3 paradoxically enhance GPVI-induced human platelet activation. Jones ML; Harper MT; Aitken EW; Williams CM; Poole AW J Thromb Haemost; 2010 Mar; 8(3):567-76. PubMed ID: 20002543 [TBL] [Abstract][Full Text] [Related]
28. Switching between low and high affinity for the Syk tandem SH2 domain by irradiation of azobenzene containing ITAM peptidomimetics. Kuil J; van Wandelen LT; de Mol NJ; Liskamp RM J Pept Sci; 2009 Oct; 15(10):685-91. PubMed ID: 19714714 [TBL] [Abstract][Full Text] [Related]
32. Platelet activation by charged ligands and nanoparticles: platelet glycoprotein receptors as pattern recognition receptors. Montague SJ; Patel P; Martin EM; Slater A; Quintanilla LG; Perrella G; Kardeby C; Nagy M; Mezzano D; Mendes PM; Watson SP Platelets; 2021 Nov; 32(8):1018-1030. PubMed ID: 34266346 [TBL] [Abstract][Full Text] [Related]
33. Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling. Suzuki-Inoue K; Tulasne D; Shen Y; Bori-Sanz T; Inoue O; Jung SM; Moroi M; Andrews RK; Berndt MC; Watson SP J Biol Chem; 2002 Jun; 277(24):21561-6. PubMed ID: 11943772 [TBL] [Abstract][Full Text] [Related]
34. A novel association of Fc receptor gamma-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets. Tsuji M; Ezumi Y; Arai M; Takayama H J Biol Chem; 1997 Sep; 272(38):23528-31. PubMed ID: 9295288 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the GPVI inhibitors losartan and honokiol. Onselaer MB; Nagy M; Pallini C; Pike JA; Perrella G; Quintanilla LG; Eble JA; Poulter NS; Heemskerk JWM; Watson SP Platelets; 2020; 31(2):187-197. PubMed ID: 30849265 [TBL] [Abstract][Full Text] [Related]
36. Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα. Kardeby C; Fälker K; Haining EJ; Criel M; Lindkvist M; Barroso R; Påhlsson P; Ljungberg LU; Tengdelius M; Rainger GE; Watson S; Eble JA; Hoylaerts MF; Emsley J; Konradsson P; Watson SP; Sun Y; Grenegård M Blood Adv; 2019 Feb; 3(3):275-287. PubMed ID: 30700416 [TBL] [Abstract][Full Text] [Related]